Cargando…
PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
BACKGROUND: Testosterone replacement therapy is the standard treatment for male hypogonadism (MH). Prescribing rates of testosterone in the UK have risen between 2001 and 2010 without an observable increase in the prevalence of hypogonadism, which may reflect increasing media awareness among men abo...
Autores principales: | Jayasena, Channa, Hudson, Miss Jemma, Cruickshank, Dr Moira, Kennedy, Miss Chalotte, Quinton, Dr Richard, Aceves-Martins, Dr Magaly, Gillies, Dr Katie, Manson, Mr Paul, Dhillo, Prof Waljit S, Bhattacharya, Prof Siladitya, Brazzelli, Dr Miriam, Hernãndez, Rodolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627445/ http://dx.doi.org/10.1210/jendso/bvac150.1447 |
Ejemplares similares
-
PMON258 Patient-Reported Outcomes for men with Hypogonadism and the Impact of Low Testosterone Levels: a review of measures
por: Jayasena, Channa N, et al.
Publicado: (2022) -
Identifying the outcomes important to men with hypogonadism: A qualitative evidence synthesis
por: Aceves‐Martins, Magaly, et al.
Publicado: (2022) -
ODP099 Hyperparathyroidism Causing life Threatening Hypercalcaemia in Pregnancy
por: Lee, Jessica, et al.
Publicado: (2022) -
Superlinear parabolic problems: blow-up, global existence and steady states
por: Quittner, Prof Dr Pavol, et al.
Publicado: (2019) -
Covid-19 quarantine dramatically affected sexual behavior: is there a possibility to go back to normality?
por: Giordano, Dr. Alessandro, et al.
Publicado: (2022)